Kuehne+Nagel supports Sanofi in multiple countries worldwide, including Hungary, the UK, and the UAE, by providing customised ...

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

March 11, 2025 Barclays 27th Annual Global Healthcare Conference, Miami Beach, FL Fireside chat: March 12, 2025, from ...

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other ... generative AI helps ...

The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...

Sanofi and CD&R sign Opella share purchase agreementParis, February 19, 2025. Following completion of the required social and corporate ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been accepted for priority review by the US Food and Drug Administration (FDA ...

Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed ...